← Back to Search

Behavioural Intervention

Dietary Interventions for Carbohydrate Intolerance

N/A
Recruiting
Led By Anna Hunter, MD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
BMI: within normal range for age
Age: 5-18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 63 days
Awards & highlights

Study Summary

This trial will compare two diets to see which is more effective at reducing abdominal pain caused by simple sugar intolerance. It will also measure the impact of the diets on the microbiome.

Who is the study for?
This trial is for kids and teens aged 5-18 with normal BMI who experience abdominal pain due to simple sugar intolerance, as shown by a positive fructose breath test. They must be willing to follow specific diets (low FODMAP or low added sugars) and provide samples. It's not for those with intestinal disorders like IBD, food allergies, or significant dietary restrictions.Check my eligibility
What is being tested?
The study compares the effects of two diets on abdominal pain caused by sugar intolerance: one group follows a Low-FODMAP diet while the other eliminates added sugars. The impact on gut bacteria and their products will also be assessed.See study design
What are the potential side effects?
Potential side effects from these dietary changes may include initial discomfort such as bloating or constipation as the body adjusts to new eating habits. However, individual experiences may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My BMI is within the normal range for my age.
Select...
I am between 5 and 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~63 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 63 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Abdominal Pain
Effect of each diet on microbiome and metabolome

Trial Design

2Treatment groups
Experimental Treatment
Group I: Low FODMAP groupExperimental Treatment1 Intervention
Participants randomized to this group will be instructed based on published low-FODMAP diet guidelines and provided with sample meal plans to aid in compliance. Each participant will be randomized to low-FODMAP diet group (LFD) for 3 weeks.
Group II: Low Added Sugar groupExperimental Treatment1 Intervention
Each participant will be randomized to either the low-FODMAP diet group (LFD) or the low added sugar diet group (LAS) for 3 weeks. Each participant will be randomized to the low added sugar diet group (LAS) for 3 weeks.

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
974 Previous Clinical Trials
7,385,872 Total Patients Enrolled
University of OregonOTHER
80 Previous Clinical Trials
46,866 Total Patients Enrolled
Oregon State UniversityOTHER
50 Previous Clinical Trials
8,401 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age restriction for the experimental protocol?

"Applicants of this medical experiment must be within the age group of 5 to 18 years old in order to qualify."

Answered by AI

Are there opportunities for qualified participants to join the current clinical trial?

"According to clinicaltrials.gov, this medical trial is actively recruiting participants right now. The study was first unveiled on October 1st 2023 and modified for the last time on September 21st 2023."

Answered by AI

Is there an opportunity to partake in this research trial?

"Candidates with carbohydrate intolerance aged between 5 and 18 are eligible for this experimental trial, which seeks to enroll 40 participants."

Answered by AI

How many individuals are involved in this experiment?

"Affirmative. Clinicaltrials.gov's records show that this clinical trial, which was initially posted on October 1st 2023, is actively enrolling participants. 40 people are required to take part in the study and it will be conducted at a single location."

Answered by AI
~27 spots leftby Feb 2026